On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone
Q Bio has raised $27.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Q Bio's investors include Andreessen Horowitz, Alumni Ventures, Khosla Ventures, Founders Fund, Kaiser Permanente.
Q Bio is headquartered in San Carlos, United States.
On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone
Q Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Q Bio — Funding & Investors." VCBacked, July 18, 2024, https://www.vcbacked.co/company/q-bio. Accessed August 16, 2026.
VCBacked. (2024). Q Bio — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/q-bio
{{cite web |title=Q Bio — Funding & Investors |url=https://www.vcbacked.co/company/q-bio |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated